Institution
University of Saskatchewan
Education•Saskatoon, Saskatchewan, Canada•
About: University of Saskatchewan is a education organization based out in Saskatoon, Saskatchewan, Canada. It is known for research contribution in the topics: Population & Health care. The organization has 25021 authors who have published 52579 publications receiving 1483049 citations. The organization is also known as: USask.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The preprocessing operations and the state of the art methods of MRI-based brain tumor segmentation are introduced, the evaluation and validation of the results are discussed, and an objective assessment is presented.
279 citations
••
TL;DR: It is shown that all the methods discussed, including Runge-Kutta, Liou's method and randomization, are closely related, but that the method of randomization is superior to the other two methods.
279 citations
••
TL;DR: In this article, the variability of stratospheric aerosol loading between 1985 and 2010 is explored with measurements from SAGE II, CALIPSO, GOMOS/ENVISAT, and OSIRIS/Odin space-based instruments.
Abstract: The variability of stratospheric aerosol loading between 1985 and 2010 is explored with measurements from SAGE II, CALIPSO, GOMOS/ENVISAT, and OSIRIS/Odin space-based instruments. We find that, following the 1991 eruption of Mount Pinatubo, stratospheric aerosol levels increased by as much as two orders of magnitude and only reached "background levels" between 1998 and 2002. From 2002 onwards, a systematic increase has been reported by a number of investigators. Recently, the trend, based on ground-based lidar measurements, has been tentatively attributed to an increase of SO2 entering the stratosphere associated with coal burning in Southeast Asia. However, we demonstrate with these satellite measurements that the observed trend is mainly driven by a series of moderate but increasingly intense volcanic eruptions primarily at tropical latitudes. These events injected sulfur directly to altitudes between 18 and 20 km. The resulting aerosol particles are slowly lofted into the middle stratosphere by the Brewer-Dobson circulation and are eventually transported to higher latitudes.
278 citations
••
TL;DR: The current results suggest that physicians should use the lowest dose of l-dopa that provides satisfactory clinical control to minimize the risk of both dyskinesia and wearing-off.
Abstract: The Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) study compared the initiation of levodopa (l-dopa) therapy with l-dopa/carbidopa (LC) versus l-dopa/carbidopa/entacapone (LCE) in patients with Parkinson's disease. In the current study, the STRIDE-PD study population was investigated to determine the effect of l-dopa dose and other risk factors on the development of dyskinesia and wearing-off. Patients were randomized to receive LCE (n=373) or LC (n=372). Blinded assessments for dyskinesia and wearing-off were performed at 3-month intervals for the 134- to 208-week duration of the study. The patients were divided into 4 dose groups based on nominal l-dopa dose at the time of onset of dyskinesia (or at study conclusion if there was no dyskinesia): group 1, 600 mg/day (n=77). Similar analyses were performed with respect to wearing-off and any motor complication. The times to onset and frequency of dyskinesia, wearing-off, or any motor complication were compared using the log-rank test (overall trend test) and a Cox proportional hazards model (pairwise comparisons). A stepwise Cox proportional hazards model was used to screen predictive factors in a multivariate analysis. The risk of developing dyskinesia and wearing-off increased in an l-dopa dose-dependent manner (P<0.001 for both). Analyses using l-dopa equivalent doses produced comparable results. Factors that were predictive of dyskinesia, in rank order, were: young age at onset, higher l-dopa dose, low body weight, North American geographic region, LCE treatment group, female gender, and more severe Unified Parkinson's Disease Rating Scale (UPDRS) Part II. Multivariate analyses identified similar predictors for wearing-off but included baseline UPDRS Part III and excluded weight and treatment allocation. The risk of developing dyskinesia or wearing-off was closely linked to l-dopa dose. The current results suggest that physicians should use the lowest dose of l-dopa that provides satisfactory clinical control to minimize the risk of both dyskinesia and wearing-off.
278 citations
••
TL;DR: The development of drugs that limit or prevent the attack of free radicals on neurons would be an important advance in the treatment of these conditions.
Abstract: Oxygen free radicals, any chemical moiety containing an oxygen atom with an unpaired electron in the outer orbital shell, are generated during many normal biochemical reactions in living tissue. The unpaired electron makes these compounds highly reactive and they can initiate disruptive peroxidation reactions with various substrates important to the survival of cells such as proteins, lipids and nucleic acids. A fairly complex defense system has evolved to protect living tissue from free radicals and to minimize the damage they might cause. Neurons are especially vulnerable to free radical attack and impaired defenses or exposure to excess free radicals can lead to neuronal death. Free radicals contribute to neuronal loss in cerebral ischemia and hemorrhage and may be involved in the degeneration of neurons in epilepsy, schizophrenia, tardive dyskinesia, normal aging, Parkinson's Disease and Alzheimer's Disease. The development of drugs that limit or prevent the attack of free radicals on neurons would be...
278 citations
Authors
Showing all 25277 results
Name | H-index | Papers | Citations |
---|---|---|---|
Tomas Hökfelt | 158 | 1033 | 95979 |
Frederick Wolfe | 119 | 417 | 101272 |
Christopher G. Goetz | 116 | 651 | 59510 |
John P. Giesy | 114 | 1162 | 62790 |
Helmut Kettenmann | 104 | 380 | 40211 |
Paul M. O'Byrne | 104 | 605 | 56520 |
Susan S. Taylor | 104 | 518 | 42108 |
Keith A. Hobson | 103 | 653 | 41300 |
Mark S. Tremblay | 100 | 541 | 43843 |
James F. Fries | 100 | 369 | 83589 |
Gordon McKay | 97 | 661 | 61390 |
Jonathan D. Adachi | 96 | 589 | 31641 |
Wenjun Zhang | 96 | 976 | 38530 |
William C. Dement | 96 | 340 | 43014 |
Chris Ryan | 95 | 971 | 34388 |